Retatrutide Reduces Body Weight by Nearly 30% in Phase 3 TRIUMPH-1 Trial, With Gains for Sleep Apnea and Knee Pain
Orforglipron Outperforms Dapagliflozin on HbA1c and Weight in Type 2 Diabetes Trial ACHIEVE-2
Novel IL-2 Therapy Shows Promise for Atopic Dermatitis and Asthma in Phase 2b Trial at ACAAI 2025
Peanut Allergy Study at ACAAI 2025 Reveals Peak Onset Age and Key Risk Factors
Automated Insulin Delivery System Shows Promise in Very Young Children with Type 1 Diabetes
Stem Cell-Derived Islet Therapy Shows Promise for Type 1 Diabetes Treatment
